Pharma/Biotech - Page 1 | TalkMarkets
All Posts > Content under Pharma/Biotech
1 to 16 of 2271 Posts
1 2 3 ... 142
Market Wars: The Last Jedi In A Galaxy Far, Far Away
Article By: Michele Schneider
Sunday, December 17, 2017 12:39 PM EST
With a meager $200 million budget, the third new Star Wars movie takes us to a “galaxy far, far away.” Heavily funded and clearly extra-terrestrial, the market transports the bulls to their own galaxy far, far away.
In this article: IBB, QQQ, GLD, IWM, IYT, KRE, SLV, SMH, SPY, TAN, USO, UUP, XRT, TLT
Read
Week In Review: Fosun Signs $125 Million Deal For Ardelyx IBS Treatment
Article By: ChinaBio® Today
Saturday, December 16, 2017 5:21 PM EST
Fosun Pharma obtained China rights to tenapanor, an Ardelyx treatment for irritable bowel syndrome with constipation (IBS-C), in a $125 million agreement. Tenapanor is also expected to treat hyperphosphatemia related to chronic kidney disease.
In this article: HCM, ARDX, LLY
Read
Why The Dividend Aristocrats Are Good Investments To Generate Long-Term Wealth
Article By: SureDividend
Saturday, December 16, 2017 4:15 PM EST
For most, the destination of investing is financial independence. The stock market is an excellent vehicle to accomplish this. More specifically, dividend growth stocks have generated strong returns over the past several decades.
In this article: JNJ, KO, PG
Read
Global Blood Therapeutics Prices A $100.0 Million Common Stock Public Offering
Article By: NASDAQ GlobeNewswire
Friday, December 15, 2017 9:49 AM EST
Global Blood Therapeutics, Inc. today announced the pricing of its underwritten public offering of its common stock for gross proceeds of approximately $100.0 million.
In this article: GBT
Read
Will $5 Billion In Near-Term Principal Payments Sink Teva?
Article By: Shock Exchange
Friday, December 15, 2017 6:00 AM EST
Teva announced it was laying off 25% of its workforce in order to cut costs. It has $5B in principal payments due in 2018 and $19B due over the next three years. Restructuring these debt payments could create headwinds for the stock.
In this article: TEVA Also: MYL
Read
Acer Therapeutics Announces Pricing Of Underwritten Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, December 13, 2017 12:30 AM EST
The underwritten public offering of 916,667 shares of its common stock is set at a public offering price of $12.00 per share.
In this article: ACER
Read
Biotech Digest – XENT Gets FDA Approval, AGN Announces Acquisition, IONS Licenses Product
Article By: KKD Healthcare Analytics
Tuesday, December 12, 2017 10:26 AM EST
Intersect ENT Inc. reported the FDA approval for its SINUVA implant, designed to be used for treating recurrent nasal polyps in patients who have had previous ethmoid sinus surgery.
In this article: AGN, MRK, SNY, REGN, RPRX, XENT, IONS, TYHT
Read
3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise
Article By: Arpita Dutt
Monday, December 11, 2017 7:45 PM EST
At the beginning of 2017, expectations were pretty high that the pharma and biotech sector would finally see lots of mergers and acquisitions (M&As). However, that did not happen.
In this article: JUNO, BLUE, INCY Also: SNY, AMGN, JNJ, GILD
Read
E Ford Model T And Personalized Medicine
Article By: Ketan Desai
Monday, December 11, 2017 10:35 AM EST
While technology marches on, the economics of personalized medicines just don’t add up. Will they be like costly trinkets being displayed in a museum that we can watch at a distance but not own?
In this article: JUNO, KITE, EDIT
Read
3 Canadian Cannabis Trends To Watch Entering The New Year
Article By: Technical420
Monday, December 11, 2017 8:32 AM EST
The Canadian cannabis sector ended on a high note last week and many investors are monitoring how the sector closes out the year.
In this article: APHQF, TWMJF, ACBFF, PRMCF, CMMDF, MRRCF
Read
Week In Review: China Life Science Deals Total $550 Million
Article By: ChinaBio® Today
Saturday, December 9, 2017 4:13 PM EST
Pfizer (NYSE: PFE​) signed a $226 million agreement for China/Asian rights to Cresemba® (isavuconazole), an antifungal drug and Everest Medicines announced a $224 million partnership with San Diego's Arena Pharma.
In this article: JNJ, GNBT, BYSI, BMY, ARNA, BABA, PFE
Read
Viking Therapeutics - Chart Of The Day
Article By: Jim Van Meerten
Friday, December 8, 2017 5:43 PM EST
The Chart of the Day belongs to Viking Therapeutics (VKTX). The biopharmaceutical company is engaged in development of novel therapies for metabolic and endocrine disorders.
In this article: VKTX
Read
Why Are Top Analysts Obsessed With These 3 Disruptive Stocks?
Article By: TipRanks
Sunday, December 3, 2017 12:53 PM EST
Here we focus in on three stocks that have the power to disrupt- and have significant backing from the Street. All these stocks have a ‘Strong Buy’ rating from the best-performing analysts- and big upside potential from the current share price.
In this article: AMZN, CBAY, SEDG
Read
Meet Big Brother Biotechnology
Article By: Michele Schneider
Sunday, December 3, 2017 11:22 AM EST
IBB has a hand in everything you do. From headaches to depression to chronic pain to cures for most illnesses,yep, that’s IBB. IBB is the most highly speculated and volatile sector.
In this article: IBB Also: QQQ, DIA, FXI, GDX, GLD, IWM, IYR, IYT, KRE, SLV, SPY, TAN, TLT, USO, UUP, VXX, XLE, XME, XOP, XRT
Read
Week In Review: Walgreens Boots Alliance Spends $420 Million For China Pharmacy Presence
Article By: ChinaBio® Today
Saturday, December 2, 2017 4:50 PM EST
Global retail pharmacy Walgreens Boots Alliance will pay $420 million to acquire a 40% stake in Sinopharm Holding GuoDa Drug Store Co, the largest retail pharmacy chain in China.
In this article: AZN, GSK, GILD, WBA
Read
Ask Slim Market Week - Friday, Dec. 1
Video By: Steve Miller
Friday, December 1, 2017 6:09 PM EST
This was a wild week in the stock market with gains of 100 points for the Dow but the Nasdaq pulled back and Friday brought up the question of political risk in weeks to come.
In this video: CMG, CSX, FDX, JPM, LUV, M, ADSK, AMAT, GOLD, NVDA, TEVA, XLF, SPX, SQ
Watch
1 to 16 of 2271 Posts
1 2 3 ... 142